Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)Arpita P Gandhi, Scott D. Rowley, Michèle L. Donato et al.|Blood|2013Cited by 1
Access to Allogeneic Hematopoietic Cell Transplant for Patients with Hematologic Malignancies in OregonDanielle Brouillard, Eneida R. Nemecek, Staci Williamson et al.|Transplantation and Cellular Therapy|2024Cited by 0
The Impact of Telehealth Visits on Access to Transplant Care for Recipients of Allogeneic Hematopoietic Cell Transplantation in the State of OregonArpita P Gandhi, Eneida R. Nemecek, Amrita Desai et al.|Transplantation and Cellular Therapy|2024Cited by 0